MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
June 13, 2006
Jim Mueller
Foolish Investing and Boston Scientific In having bought Guidant, Boston Scientific might end up paying more than just the price. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 5, 2005
Stephen D. Simpson
Boston Scientific's Bold Move Acquiring Guidant would be risky, but it would give Boston Scientific exactly what it needs. It will be curious to see how J&J responds to this deal. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 12, 2006
Stephen D. Simpson
The Guidant Auction Continues Johnson & Johnson hopes to save the deal with a last-minute raise of its offer. Although Boston Scientific's offer is $4 per share higher, that doesn't necessarily make it the best value. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 31, 2006
Stephen D. Simpson
Can Boston Scientific Get It Right? To boost investor confidence, management must first prove itself. mark for My Articles similar articles
The Motley Fool
March 9, 2005
Tom Taulli
Oracle the Spoiler Again Oracle takes out the big guns to defend its turf against its foe, SAP. Investors, take note. mark for My Articles similar articles
InternetNews
February 28, 2005
Paul Shread
Software Consolidation Continues Shares of Retek rocketed 40% on news of being acquired by SAP... Nasdaq tumbles... Satellite radio stocks rise... etc. mark for My Articles similar articles
InternetNews
March 18, 2005
Michael Singer
Oracle's Back to Its Bidding Ways The company challenges SAP's latest offer for Retek but this time without its CFO, Henry You. mark for My Articles similar articles
Popular Mechanics
January 2009
Mike Allen
How to Read a Mechanic's Work Order: Saturday Mechanic You can troubleshoot your repair after it's done -- without turning a wrench. Here's an overview of the sometimes confusing world of the repair order. mark for My Articles similar articles
The Motley Fool
January 17, 2006
Stephen D. Simpson
High-Stakes Medical Device Chicken Boston Scientific has upped the ante again. Are they bluffing? Their latest offer is $80 a share -- $42 in cash and $38 in stock. Let's hope the board knows what it is doing, because it is staking the company on this. mark for My Articles similar articles
AskMen.com
Paul Anderson
Questions To Ask Your Mechanic A mechanic should possess the same qualities that you expect from your doctor and dentist; namely trust and reliability. No one wants to have a regular mechanic who takes advantage of him every chance he gets. Since car owners have so much resting on these grease monkeys, it's very important to find the right guy. mark for My Articles similar articles
InternetNews
October 15, 2007
Larry Barrett
Why Oracle's Tops in Takeovers Industry watchers think BEA's days are numbered: Larry Ellison and Oracle have spent years and billions mastering the art of the takeover. mark for My Articles similar articles
InternetNews
March 17, 2005
Roy Mark
SAP Boosts Offer For Retek New $629 million bid counters Oracle's $525 million offer for retail software and services firm. mark for My Articles similar articles
InternetNews
March 22, 2005
Michael Singer
Oracle, SAP: Upward Bound Analysts suggest Oracle's winning bid for the Minnesota-based retail software provider is only the tip of the iceberg when it comes to potential mergers and acquisitions in the next 12 months. mark for My Articles similar articles
The Motley Fool
November 9, 2009
Brian Orelli
Guidant: The Gift That Keeps on Giving And not in the good way. Last year, Boston Scientific took a whopping $2.7 billion goodwill writedown because it had to downgrade the value of what it got in acquiring Guidant. mark for My Articles similar articles
The Motley Fool
June 29, 2006
Jim Mueller
Guidant, Devices, and Recalls, Oh My! To repair its acquisition's good name, Boston Scientific must quickly fix Guidant's problems. One analyst sees annual growth for Guidant's devices in the 10% to 15% range. No one knows how accurate that will prove to be, but it certainly provides hope for the troubled acquisition. mark for My Articles similar articles
The Motley Fool
February 1, 2010
Brian Orelli
Now That's Some Expensive Risk Mitigation Boston Scientific avoids a trial -- but at a dear cost. mark for My Articles similar articles
InternetNews
March 11, 2005
Michael Singer
Oracle Woos, SAP Waits For Retek The two largest ERP software companies try to outbid each other in fight for retail software provider. mark for My Articles similar articles
The Motley Fool
April 18, 2006
Stephen D. Simpson
Get Ready for the New Boston Scientific Here's hoping it does a better job as a bigger business. For all of the risks that are present, there still could be rewards here for investors. mark for My Articles similar articles
The Motley Fool
September 26, 2005
Stephen D. Simpson
Boston Scientific: Finally Cheap Enough? Could shares of the medical device company now be attractive for long-term investors? mark for My Articles similar articles
InternetNews
September 19, 2005
Clint Boulton
SAP Takes Triversity For Retail SAP's acquisition of retail software maker Triversity will give the company's retail arm a big boost against Oracle. mark for My Articles similar articles
The Motley Fool
January 29, 2009
Brian Orelli
No Buyer's Remorse at Boston Scientific The pacemakers and defibrillators that Guidant contributed to Boston Scientific's bottom line are still growing strong, but the company had to take a whopping $2.7 billion goodwill writedown because the value of what it purchased has changed. mark for My Articles similar articles
The Motley Fool
January 13, 2006
Stephen D. Simpson
Once More With Guidant In the ongoing game of tit-for-tat, Boston Scientific ups its bid for Guidant. This battle will ultimately be decided by the 800-pound gorilla that is J&J. Investors, take note. mark for My Articles similar articles
InternetNews
November 22, 2005
Clint Boulton
SAP Gaining Ground in Merchant Applications The German software giant will purchase Khimetrics to keep up with Oracle in the retail applications niche. mark for My Articles similar articles
InternetNews
March 15, 2005
Michael Singer
Retail in Flux as Oracle Battles SAP Bidding war over Retek and differences in Oracle and SAP's culture are confusing the retail industry. mark for My Articles similar articles
AskMen.com
Patrick Rowlings
Know When To Dump Your Car Knowing exactly when you should dump your car is a little complicated. Here are some factors that you'll want to consider. mark for My Articles similar articles
The Motley Fool
December 8, 2004
Dave Marino-Nachison
J&J Guided to Guidant? Medical device investors felt their hearts skip as executives told The New York Times the two companies may be set to merge. mark for My Articles similar articles
The Motley Fool
March 22, 2005
Tim Beyers
Larry Ellison Wins Again The battle for retail software applications vendor Retek ends, and Oracle comes out on top. Does any of this drama matter for shareholders? mark for My Articles similar articles
InternetNews
February 28, 2005
Jim Wagner
SAP Bids on Competition The German IT giant bolsters its retail industry software presence with the purchase of one of its competitors. mark for My Articles similar articles
InternetNews
March 8, 2005
Paul Shread
Oracle Makes Bid For Retek Investors react like they expect SAP to counter... WebMD reports expected results... Nasdaq slumps... Rising oil prices affect everyone... etc. mark for My Articles similar articles
BusinessWeek
April 4, 2005
Steve Hamm
Larry, You Picked A Nasty Fight In taking on heavyweight SAP in the corporate applications software market, Oracle faces very long odds. mark for My Articles similar articles
InternetNews
September 21, 2007
Larry Barrett
Oracle Shatters 1Q Estimates Another blockbuster earnings report from Oracle ratchets up the pressure on arch-rival SAP. mark for My Articles similar articles
The Motley Fool
February 5, 2007
Ryan Fuhrmann
Boston Scientific's Unscientific Outlook There's still uncertainty as the med-tech company blends an acquisition and deals with controversy. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 20, 2006
Ryan Fuhrmann
Boston's Unscientific Results Boston Scientific reported third-quarter results that were at the upper end of the company's late-September earnings warning. The shares have had a rough run lately, down nearly 40% over the past year. Buying opportunity? mark for My Articles similar articles
The Motley Fool
March 1, 2005
Tom Taulli
SAP Revs on the M&A Autobahn Europe's largest software company proves it can do deals, too announcing its purchase of Retek. On the news, Retek's stock surged 40%. This transaction is likely to not be the last M&A deal for the German giant. mark for My Articles similar articles
The Motley Fool
October 23, 2008
Brian Orelli
Boston Scientific Should Be Thankful The medical device maker's two-year-old acquisition of Guidant has saved it in the third quarter. mark for My Articles similar articles
The Motley Fool
September 30, 2009
Brian Orelli
Boston Scientific Pays Up And Johnson & Johnson reaps the rewards. mark for My Articles similar articles
The Motley Fool
February 15, 2006
Tim Beyers
Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Boston Scientific... Franklin Bank... Fossil... Gartner... iPass... mark for My Articles similar articles
The Motley Fool
July 14, 2006
Tom Taulli
SAP Gets Zapped SAP has always been conservative on guidance, but the company finally missed its numbers -- in a big way. Investors, take note. mark for My Articles similar articles
The Motley Fool
November 7, 2005
Stephen D. Simpson
All's Not Lost at Guidant Eroding sales, a partner with cold feet, and all sorts of litigation and investigation cloud Guidant's skies. Investors, take note. mark for My Articles similar articles
InternetNews
March 22, 2005
Oracle Wins in Bid For Retek Offer of $11.25 per share wins out after rival SAP drops out of the bidding for the retail software play. mark for My Articles similar articles
Fast Company
November 2004
Kerry J. Sulkowicz
The Corporate Shrink What do you make of the role of "gut feel" in business or investment decisions?... Should I remain freelancing for a sinking ship?... mark for My Articles similar articles
The Motley Fool
February 12, 2010
Brian Orelli
Too Bad It's Not in the "Restructuring" Business Shares of Boston Scientific slipped nearly 10% yesterday, after the company released earnings and guidance for this year. mark for My Articles similar articles
The Motley Fool
May 17, 2010
Anders Bylund
Who's the Next IBM? The tech landscape is getting crowded with wannabe IBM clones. mark for My Articles similar articles
Bank Technology News
June 1, 2008
Michael Dumiak
SAP vs. Oracle: Silicon Sluggers While the blow-by-blow between SAP and Oracle can be parsed as attack-counterattack, analysts say what's going on in these transformations is more than meets the eye. mark for My Articles similar articles
The Motley Fool
May 24, 2006
S.J. Caplan
Goodbye, Guidant Publicity woes drive Boston Scientific to ditch the Guidant name. In the meantime, Boston Scientific wants to capitalize on its entry into the ICD market, an area experiencing double-digit sales growth. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 22, 2006
Anders Bylund
Oracle Delivers, Denounces a Rival Oracle's Ellison and his senior executive staff decided to rip into competitor SAP. Ellison then spent a good portion of the conference call outlining the many ways in which Oracle is outperforming its rival in enterprise-management software. mark for My Articles similar articles